Evidence map›Paper›PMID 40164812›Full record

ArticleNature reviews. Drug discovery2025

Publisher Correction: Fibrosis: cross-organ biology and pathways to development of innovative drugs.

Florian Rieder, Laura E Nagy, Toby M Maher, Jörg H W Distler, Rafael Kramann, Boris Hinz, Marco Prunotto

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature reviews. Drug discovery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Florian Rieder *Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA. riederf@ccf.org.ORCID http://orcid.org/0000-0002-9087-1568
Laura E Nagy *Department of Gastroenterology, Hepatology and Nutrition, Digestive Disease Institute, Cleveland Clinic, Cleveland, OH, USA.ORCID http://orcid.org/0000-0002-0580-2809
Toby M Maher *Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.ORCID http://orcid.org/0000-0001-7192-9149
Jörg H W Distler *Department of Rheumatology, University Hospital Düsseldorf, Heinrich-Heine-University, Düsseldorf, Germany.
Rafael Kramann *Department of Nephrology and Clinical Immunology, RWTH Aachen; Medical Faculty, Aachen, Germany.
Boris Hinz *Keenan Research Institute for Biomedical Science of the St Michael's Hospital, Toronto, Ontario, Canada.ORCID http://orcid.org/0000-0002-0526-393X
Marco Prunotto *Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Geneva, Switzerland. marco.prunotto@unige.ch.ORCID http://orcid.org/0000-0002-0203-0129

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40164812

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.